Pharmacoinvasive strategy in the treatment of acute myocardial infarction: current state-of-the-art
The existing clinical guidelines identify two main approaches to the treatment of patients with ST-segment elevation myocardial infarction: a primary percutaneous coronary intervention and a pharmacoinvasive strategy. Due to the time delays due to various reasons, it is not always easy to perform pr...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2021-07-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4452 |
| Summary: | The existing clinical guidelines identify two main approaches to the treatment of patients with ST-segment elevation myocardial infarction: a primary percutaneous coronary intervention and a pharmacoinvasive strategy. Due to the time delays due to various reasons, it is not always easy to perform primary percutaneous coronary intervention timely (<120 minutes). Modern thrombolytic drugs make it easy and safe to apply a pharmacoinvasive strategy to a wide group of patients, improving their prognosis. |
|---|---|
| ISSN: | 1560-4071 2618-7620 |